What is the maximum recommended dose of Buspar (buspirone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dose of Buspirone (Buspar)

The maximum recommended dose of buspirone is 60 mg per day, typically divided into three doses. 1

Dosing Guidelines

Buspirone dosing follows a structured approach:

  • Starting dose: 15 mg/day (5 mg three times daily)
  • Titration: Increase by 5 mg every 2-3 days as needed
  • Maintenance dose: 15-30 mg/day is the most common effective range
  • Maximum dose: 60 mg/day

Dosing Schedule Options

  • Three times daily (TID): 10 mg TID (30 mg/day) is a common effective regimen
  • Twice daily (BID): 15 mg BID (30 mg/day) is equally effective with potentially better compliance 2

Pharmacokinetic Considerations

Understanding buspirone's pharmacokinetics helps explain the dosing recommendations:

  • Bioavailability: Only about 4% of an oral dose reaches systemic circulation
  • Half-life: Approximately 2.5 hours
  • Metabolism: Extensively metabolized by the liver
  • Food effect: Taking with food increases bioavailability 2-fold
  • Linear pharmacokinetics: Observed in the 10-40 mg dose range 3

Safety at Higher Doses

  • Long-term studies have shown that most patients are successfully managed on daily doses ranging from 15 to 30 mg/day 4
  • In clinical trials, doses as high as 90 mg/day have been used safely in depression studies 5
  • Healthy volunteers have tolerated single doses up to 375 mg in pharmacology trials 1

Special Populations

Dose adjustments may be necessary in:

  • Hepatic impairment: Significant reduction in dosage required (plasma concentrations can be 15-fold higher)
  • Renal impairment: Moderate reduction in dosage recommended (2-fold increase in plasma concentrations)
  • Elderly: No specific dose adjustment required based on age alone 3

Drug Interactions

Dose reduction is necessary when buspirone is co-administered with:

  • CYP3A4 inhibitors (e.g., verapamil, diltiazem, erythromycin, itraconazole)
  • Avoid combination with MAO inhibitors

Overdose Considerations

While buspirone has a favorable safety profile even at higher doses, symptoms of overdose may include:

  • Nausea, vomiting, dizziness
  • Drowsiness, miosis
  • Gastric distress

No deaths have been reported from buspirone overdose alone, and complete recovery is the usual outcome 1

Clinical Monitoring

When prescribing buspirone at higher doses:

  • Monitor for side effects (dizziness, headache, nausea are most common)
  • Reassess the need for continued therapy periodically
  • No withdrawal syndrome has been observed after abrupt discontinuation, even after long-term use 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.